A fair MC for is now1 Billion. MC was over 1.2 billion back in Feb 2020 and was overvalued at that point.
But now with further FDA approval 1 Billion MC plus would be appropriate.
Projected revenue by 2023 is 100million (Morningstar). I think this is conservative.
Expect reduced costs and revenue pop next Quarterly.
I wonder how many of the Paed burn centres will order RECELL units before June 30, or if it will be next Qtr? As I understand a good percentage of them have been using RCELL for years under compassionate use so no need for training required in those units.
Regardless this is undervalued at current Market Cap by a fair way.
This has growth written all over it.
Next stop, Japan. Broad label approval by JPMDA is expected.
$10 by Xmas 2021, page-3
-
- There are more pages in this discussion • 302 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.08 |
Change
-0.110(3.45%) |
Mkt cap ! $215.7M | |||
| Open | High | Low | Value | Volume |
| $3.08 | $3.10 | $3.04 | $150.2K | 48.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4767 | $3.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.08 | 824 | 4 |
View Market Depth
| Last trade - 12.13pm 01/11/2024 (20 minute delay) ? |
| AVH (ASX) Chart |